EMA Withdrawn: Doribax (doripenem) — Janssen-Cilag International NV

View source ↗

Summary

Doribax (doripenem) has been withdrawn from the European market by Janssen-Cilag International NV due to regulatory decision.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infection
• Cross Infection
• Pneumonia Bacterial
• Pneumonia Ventilator-associated
• Urinary Tract Infection

Drugs mentioned

• Doribax (doripenem)

Snippet

Status: Withdrawn. Therapeutic area: Pneumonia, Ventilator-Associated;Pneumonia, Bacterial;Urinary Tract Infections;Bacterial Infections;Cross Infection. MAH: Janssen-Cilag International NV. Decision date: 21/02/2012